ATE522508T1 - Phenobarbitalderivate zur verwendung in immuntests - Google Patents
Phenobarbitalderivate zur verwendung in immuntestsInfo
- Publication number
- ATE522508T1 ATE522508T1 AT08839884T AT08839884T ATE522508T1 AT E522508 T1 ATE522508 T1 AT E522508T1 AT 08839884 T AT08839884 T AT 08839884T AT 08839884 T AT08839884 T AT 08839884T AT E522508 T1 ATE522508 T1 AT E522508T1
- Authority
- AT
- Austria
- Prior art keywords
- phenobarbital
- antibody specific
- immune tests
- phenobarbital derivatives
- derivatives
- Prior art date
Links
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical class C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002695 phenobarbital Drugs 0.000 abstract 2
- CKRJGDYKYQUNIM-UHFFFAOYSA-N 3-fluoro-2,2-dimethylpropanoic acid Chemical compound FCC(C)(C)C(O)=O CKRJGDYKYQUNIM-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000002820 assay format Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98120207P | 2007-10-19 | 2007-10-19 | |
| PCT/EP2008/008750 WO2009049884A1 (en) | 2007-10-19 | 2008-10-16 | Phenobarbital derivatives useful in immunoassay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522508T1 true ATE522508T1 (de) | 2011-09-15 |
Family
ID=40293606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08839884T ATE522508T1 (de) | 2007-10-19 | 2008-10-16 | Phenobarbitalderivate zur verwendung in immuntests |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8133743B2 (de) |
| EP (1) | EP2205571B1 (de) |
| JP (1) | JP5314032B2 (de) |
| CN (1) | CN101821244B (de) |
| AT (1) | ATE522508T1 (de) |
| CA (1) | CA2695460C (de) |
| ES (1) | ES2371801T3 (de) |
| WO (1) | WO2009049884A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102323414B (zh) * | 2011-06-07 | 2013-09-11 | 西安金域医学检验所有限公司 | 一种苯巴比妥均相酶免疫检测试剂盒及其制备方法 |
| JP6389176B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ．ベー． | アリピプラゾールハプテンに対する抗体及びその使用 |
| WO2014031656A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine haptens and use thereof |
| CA2882562C (en) | 2012-08-21 | 2019-08-27 | Eric Hryhorenko | Antibodies to aripiprazole and use thereof |
| JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス，インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| JP6131414B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ．ベー． | アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用 |
| CN116179496B (zh) * | 2022-12-09 | 2024-01-26 | 江南大学 | 一株分泌抗苯巴比妥单克隆抗体的杂交瘤细胞株及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4279992A (en) * | 1978-03-13 | 1981-07-21 | Miles Laboratories, Inc. | Specific binding assay employing an enzyme-cleavable substrate as label |
| US4255566A (en) * | 1980-02-19 | 1981-03-10 | Miles Laboratories | Flavin adenine dinucleotide derivatives and labeled conjugates prepared therefrom |
| US4363874A (en) * | 1981-08-07 | 1982-12-14 | Miles Laboratories, Inc. | Multilayer analytical element having an impermeable radiation nondiffusing reflecting layer |
| US4614823A (en) * | 1982-11-08 | 1986-09-30 | Abbott Laboratories | Aminomethylfluorescein derivatives |
| US4543412A (en) * | 1983-11-04 | 1985-09-24 | Abbott Laboratories | Phenobarbital enzyme inhibitors |
| US6472227B1 (en) * | 1986-06-04 | 2002-10-29 | Abbott Laboratories | Barbiturate assay, tracers, immunogens, antibodies and kit |
| ES2104566T3 (es) * | 1989-03-10 | 1997-10-16 | Hoffmann La Roche | Reactivos para la determinacion de drogas. |
| US5099020A (en) * | 1989-11-27 | 1992-03-24 | Abbott Laboratories | Barbiturate assay compositions and methods |
| US5096838A (en) * | 1989-11-27 | 1992-03-17 | Abbott Laboratories | Barbiturate assay compositions and methods |
| CA2062240A1 (en) * | 1991-06-07 | 1992-12-08 | Susan J. Danielson | Labeled hydantoin derivatives for immunoassays |
| US5284948A (en) * | 1991-06-07 | 1994-02-08 | Eastman Kodak Company | Drug hapten analogues for immunoassays |
| DE69232002T2 (de) | 1991-06-07 | 2002-06-06 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays unter Verwendung von markierten Hapten-Analogen |
| US5414085A (en) * | 1992-04-06 | 1995-05-09 | Biosite Diagnostics, Inc. | Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| US7642059B2 (en) * | 2005-09-07 | 2010-01-05 | Roche Diagnostics Operations, Inc. | Single receptor assays for immunosuppressive drugs |
-
2008
- 2008-09-23 US US12/236,073 patent/US8133743B2/en active Active
- 2008-10-16 ES ES08839884T patent/ES2371801T3/es active Active
- 2008-10-16 AT AT08839884T patent/ATE522508T1/de not_active IP Right Cessation
- 2008-10-16 EP EP08839884A patent/EP2205571B1/de active Active
- 2008-10-16 CN CN2008801114977A patent/CN101821244B/zh active Active
- 2008-10-16 CA CA2695460A patent/CA2695460C/en not_active Expired - Fee Related
- 2008-10-16 WO PCT/EP2008/008750 patent/WO2009049884A1/en not_active Ceased
- 2008-10-16 JP JP2010529288A patent/JP5314032B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20090104713A1 (en) | 2009-04-23 |
| US8133743B2 (en) | 2012-03-13 |
| ES2371801T3 (es) | 2012-01-10 |
| EP2205571A1 (de) | 2010-07-14 |
| WO2009049884A1 (en) | 2009-04-23 |
| HK1144819A1 (en) | 2011-03-11 |
| CN101821244B (zh) | 2012-09-05 |
| JP5314032B2 (ja) | 2013-10-16 |
| CN101821244A (zh) | 2010-09-01 |
| JP2011500615A (ja) | 2011-01-06 |
| EP2205571B1 (de) | 2011-08-31 |
| CA2695460C (en) | 2013-01-08 |
| CA2695460A1 (en) | 2009-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE522508T1 (de) | Phenobarbitalderivate zur verwendung in immuntests | |
| EP2224921A4 (de) | Modulation der immunantwort | |
| CY1116261T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
| NI201100107A (es) | Combinaciones antitumorales que contienen anticuerpos que reconocen específicamente la cd38 y la citarabina. | |
| EA201170227A1 (ru) | Имидазолкарбоксамиды | |
| CU20120095A7 (es) | Antagonistas de pcsk9 | |
| CR10273A (es) | "anticuerpos anti-5t4 y usos de los mismos" | |
| JO3118B1 (ar) | تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة | |
| CY1114926T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
| EA201200565A1 (ru) | ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА | |
| EA201100306A1 (ru) | Производные циклогексиламида и их применение в качестве антагонистов рецептора crf-1 | |
| EP2282773A4 (de) | Verfahren und zusammensetzungen zur herstellung von antikörpern und antikörperderivaten mit reduzierter kernfukosylierung | |
| EP2569330A4 (de) | Chlorotoxin-varianten und -konjugate sowie verfahren zu ihrer verwendung | |
| CL2008003910A1 (es) | Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida. | |
| WO2009142810A3 (en) | Methods for treating or preventing colorectal cancer | |
| NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
| WO2009111586A3 (en) | Autonomous in vitro evolution | |
| MX2009005696A (es) | Nanoparticulas magneticas para la aplicacion en hipertermia, preparacion de las mismas y uso en constructos que tienen una aplicacion farmacologica. | |
| AR063026A1 (es) | Anticuerpos dirigidos contra ccr5 y la utilizacion de los mismos | |
| CY1116189T1 (el) | Σταθερη υγρη φαρμακευτικη συνθεση με βαση την τραζοδονη | |
| ECSP11011190A (es) | Anticuerpos monoclonales anti-rhd | |
| CY1110213T1 (el) | Παραγωγα αζολοπυριδιν-2-ονης ως αναστολεις λιπασων και φωσφολιπασων | |
| DK1655318T3 (da) | Lavviskose, vandige, strålehærdelige urethan-bindemiddeldispersioner med højt indhold af faste legemer | |
| EA200870148A1 (ru) | Производные сулиндака, их применение и получение | |
| SG162766A1 (en) | Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |